Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending September 2, 2023 (Week 35)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2023 †Cum YTD 2022 †
U.S. Residents, excluding U.S. Territories 13,528 33,418 965,265 1,101,917
New England 179 1,650 24,574 35,490
Connecticut - 430 1,155 8,350
Maine 49 74 1,976 2,155
Massachusetts - 709 15,463 19,096
New Hampshire - 82 1,776 1,944
Rhode Island 106 694 3,298 3,082
Vermont 24 37 906 863
Middle Atlantic 2,554 4,218 130,119 129,603
New Jersey 532 788 22,163 22,351
New York (excluding New York City) 877 1,032 27,925 26,692
New York City 422 1,457 44,123 43,356
Pennsylvania 723 1,233 35,908 37,204
East North Central 1,501 4,622 127,268 154,569
Illinois 108 1,811 33,588 48,225
Indiana 100 837 18,434 22,813
Michigan 242 975 21,695 28,748
Ohio 660 1,204 36,792 37,166
Wisconsin 391 562 16,759 17,617
West North Central 933 2,153 61,972 68,763
Iowa 98 334 8,996 10,005
Kansas 87 325 6,121 9,584
Minnesota 124 497 14,354 14,990
Missouri 571 745 21,483 21,717
Nebraska - 241 5,956 6,565
North Dakota 1 92 1,774 2,414
South Dakota 52 125 3,288 3,488
South Atlantic 3,098 7,249 219,344 229,668
Delaware 147 210 3,815 3,477
District of Columbia 4 199 5,290 5,510
Florida 1,564 2,786 75,963 71,798
Georgia - 1,597 42,665 49,614
Maryland U NC U U
North Carolina 8 1,445 38,188 44,030
South Carolina 624 766 22,440 24,478
Virginia 720 976 28,129 27,694
West Virginia 31 104 2,854 3,067
East South Central 1,061 2,450 65,403 75,198
Alabama 634 972 23,093 20,821
Kentucky 348 555 11,088 12,185
Mississippi 79 483 11,490 16,016
Tennessee - 1,094 19,732 26,176
West South Central 492 4,957 112,779 159,490
Arkansas - 436 10,716 12,210
Louisiana 429 810 24,019 24,936
Oklahoma 63 451 7,033 14,032
Texas - 3,399 71,011 108,312
Mountain 827 2,523 69,794 79,570
Arizona 500 918 26,298 27,967
Colorado - 778 17,041 17,595
Idaho 53 148 3,825 3,882
Montana 32 100 2,060 2,821
Nevada 42 367 6,232 10,952
New Mexico 20 257 5,825 7,625
Utah 157 253 7,418 7,565
Wyoming 23 52 1,095 1,163
Pacific 2,883 5,049 154,012 169,566
Alaska 17 121 2,681 3,665
California 2,222 4,112 127,653 131,575
Hawaii - 142 - 3,709
Oregon 317 383 10,236 10,667
Washington 327 590 13,442 19,950
U.S. Territories - 124 1,138 3,168
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 124 1,138 3,168
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 2 7 41 95
Total 13,530 33,518 966,444 1,105,180
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2022 and 2023 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.